Short-Read Sequencing Market to Grow with a CAGR of 13.89% through 2029
Rising
prevalence of genetic disorders and cancers is expected to drive the Global Short-Read
Sequencing Market growth in the forecast period, 2025-2029.
According to
TechSci Research report, “Short-Read Sequencing Market – Global Industry
Size, Share, Trends, Competition Forecast & Opportunities, 2029”,
the Global Short-Read Sequencing Market stood at USD 5.42 Billion in 2023 and
is anticipated to grow with a CAGR of 13.89% in the forecast period, 2025-2029.The
rising prevalence of genetic disorders and cancers worldwide is driving the
adoption of short read sequencing technologies in clinical diagnostics.
NGS-based tests offer comprehensive genomic profiling that can aid in the early
detection, diagnosis, and management of genetic diseases and cancer subtypes.
Additionally, short read sequencing facilitates the identification of
actionable mutations and genetic predispositions, enabling precision medicine
approaches for personalized treatment strategies. With the increasing burden of
genetic diseases and cancers, there is a growing need for accurate and
cost-effective sequencing solutions, thereby fueling market growth.
Technological
advancements in sequencing platforms have been instrumental in driving the
growth of the global short read sequencing market. Innovations such as improved
sequencing chemistries, enhanced instrument throughput, and reduced sequencing
costs have expanded the capabilities and accessibility of NGS technologies.
Additionally, the development of portable and benchtop sequencers has
democratized sequencing, enabling researchers and clinicians to perform genomic
analysis in diverse settings. Furthermore, advancements in bioinformatics tools
and data analysis pipelines have facilitated the interpretation and utilization
of genomic data generated by short read sequencing platforms, driving adoption
across various applications.
The adoption of
short read sequencing technologies is not limited to clinical diagnostics but
extends to non-clinical applications such as agriculture, forensics, and
environmental monitoring. In agriculture, NGS-based assays are used for crop
improvement, livestock breeding, food safety testing, driving efficiency and
sustainability in agricultural practices. In forensics, short read sequencing
enables the analysis of DNA evidence for criminal investigations and
identification purposes. Moreover, environmental scientists utilize NGS
technologies to study microbial communities, biodiversity, and ecological
interactions, contributing to our understanding of environmental dynamics and
conservation efforts. The versatility of short read sequencing platforms across
diverse applications is driving market expansion beyond the healthcare sector.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Short-Read Sequencing Market”
The Global Short-Read
Sequencing Market is segmented into product,
application, end-user, regional distribution, and company.
Based
on the Product, Consumables segment emerged as the dominant segment in the
Global Short-Read Sequencing market in 2023. As the number of sequencing
experiments conducted worldwide continues to rise, the consumption of
consumables also increases proportionally, driving market growth in this
segment. Furthermore, technological advancements and innovations in short-read
sequencing platforms have led to the development of new and improved
consumables with enhanced performance and efficiency. companies are developing
novel reagents and kits that enable faster library preparation, higher
sequencing throughput, and improved data quality, catering to the evolving
needs of researchers and clinicians. Moreover,
the competitive pricing and availability of consumables from multiple vendors
further contribute to the dominance of the Consumables segment in the Global
Short-Read Sequencing market.
Based on the
Application, targeted sequencing & resequencing segment emerged as the
dominant segment in the Global Short-Read Sequencing market in 2023.
Furthermore, advancements in sequencing technologies and bioinformatics tools
have made targeted sequencing more accessible and cost-effective, driving
adoption across research institutions, clinical laboratories, and biotechnology
firms. Companies are developing innovative targeted sequencing assays, panels,
and kits that offer high specificity, sensitivity, and coverage, catering to
the diverse needs of researchers and clinicians. Moreover, the versatility of
targeted sequencing and resequencing makes it applicable across a wide range of
research and clinical applications, including cancer profiling, genetic
screening, infectious disease diagnosis, and agricultural genomics. This broad
applicability further contributes to the dominance of the targeted sequencing
and resequencing segment in the Global Short-Read Sequencing market.
North America
emerged as the dominant player in the Global Short-Read Sequencing Market in
2023, holding the largest market share. North America benefits from a strong
network of healthcare institutions and clinical laboratories that leverage
short-read sequencing technologies for genomic analysis, clinical diagnostics,
and personalized medicine applications. The region's advanced healthcare
infrastructure, coupled with high healthcare expenditure and reimbursement
policies, encourages the adoption of genomic technologies in clinical settings,
driving market demand. Additionally,
strategic collaborations and partnerships between industry players, academic
institutions, and healthcare organizations in North America have facilitated
technology transfer, knowledge exchange, and market expansion. These
collaborations have accelerated the development and commercialization of
innovative sequencing solutions tailored to the diverse needs of researchers,
clinicians, and patients in the region.
Major companies
operating in Global Short-Read Sequencing Market are:
- Illumina, Inc.
- Invitae Corporation
- Thermo Fisher Scientific, Inc.
- Pacific Biosciences of California, Inc.
- BGI Genomics Co., Ltd
- QIAGEN NV
- Agilent Technologies
- Azenta US, Inc. (GENEWIZ)
- PerkinElmer, Inc.
- ProPhase Labs, Inc. (Nebula Genomics)
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The
Global Short-Read Sequencing Market is poised for significant growth in the
coming years. Technological advancements, such as improvements in sequencing
platforms and bioinformatics tools, are enhancing the accuracy, speed, and
affordability of short-read sequencing. Additionally, the rising demand for
personalized medicine and precision healthcare is fueling the adoption of
short-read sequencing technologies for genomic profiling and targeted
therapies. Moreover, the increasing prevalence of genetic disorders, cancers,
and infectious diseases worldwide is driving the need for comprehensive genomic
analysis in research and clinical diagnostics. Furthermore, the expansion of
short-read sequencing applications in non-clinical sectors, such as
agriculture, forensics, and environmental monitoring, is creating new
opportunities for market growth.” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based management consulting firm.
“Short-Read
Sequencing Market - Global Industry Size, Share, Trends, Opportunity, and
Forecast, 2019-2029F Segmented By Product (Instruments, Consumables, Services),
By Application (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing
& Resequencing, Others), By End User (Academic & Research Institutes,
Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others)
Region and Competition”, has evaluated the future growth potential of Global
Short-Read Sequencing Market and provides statistics & information on
market size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Short-Read
Sequencing Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com